Boston biotech Avalyn Pharma filed to go public on Nasdaq to fund trials for its inhaled drugs treating rare lung diseases ...
AI is reshaping how infrastructure is built and scaled,” Intel CEO Lip-Bu Tan said in a statement. “Scaling AI requires more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results